FUNCTIONALLY-MODIFIED OLIGONUCLEOTIDES AND SUBUNITS THEREOF
申请人:Sarepta Therapeutics, Inc.
公开号:US20140330006A1
公开(公告)日:2014-11-06
Functionally-modified oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3′ and/or 5′-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.
USE OF PTERIDINONE DERIVATIVE SERVING AS EGFR INHIBITOR
申请人:East China University Of Science And Technology
公开号:EP3312180A1
公开(公告)日:2018-04-25
The present invention relates to a pteridinone derivative serving as an EGFR inhibitor and use thereof. Specifically, the present invention relates to a compound represented by the following formula I, pharmaceutical composition comprising the compound of the following formula I, and use of the compound in preparation of drugs for treating EGFR-mediated diseases or inhibiting EGFR.
[EN] USE OF PTERIDINONE DERIVATIVE SERVING AS EGFR INHIBITOR<br/>[FR] UTILISATION DE DÉRIVÉS DE PTÉRIDINONE EN TANT QU'INHIBITEUR DE L'EGFR<br/>[ZH] 蝶啶酮衍生物作为EGFR抑制剂的应用